ELTP

Elite Pharmaceuticals (QB) Stock Price

0.066
0.002 (3.13%)
0.066
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Elite Pharmaceuticals Inc (QB) ELTP OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.002 3.13% 0.066 16:32:40
Close Price Low Price High Price Open Price Previous Close
0.066 0.0615 0.067 0.063675 0.064
Bid Price Ask Price Spread News
0.0612 0.0675 0.0063 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
52 394,722 $ 0.063538 $ 25,080 639,930 0.048 - 0.115
Last Trade Time Type Quantity Stock Price Currency
15:55:41 1,000 $ 0.066 USD

Elite Pharmaceuticals (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 66.61M 1.01B 793.80M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
73.81k $ - 0.00% - -

more financials information »

Elite Pharmaceuticals (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ELTP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.06350.0680.060.0654268463,9470.00253.94%
1 Month0.0650.07150.060.0661404421,3550.0011.54%
3 Months0.0650.0850.05710.0690587606,3380.0011.54%
6 Months0.0870.09950.05710.0759989691,802-0.021-24.14%
1 Year0.0810.1150.0480.0836832819,365-0.015-18.52%
3 Years0.09290.1450.03330.0884371768,705-0.0269-28.96%
5 Years0.2330.4430.03330.1671628985,389-0.167-71.67%

Elite Pharmaceuticals (QB) Description

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, manufacturing, and packaging of niche generic products, which are then distributed by exclusive marketing partners. Elite specializes in oral sustained and controlled release drug products that have high barriers to entry. Elite owns generic products which have been licensed to TAGI Pharma, Glenmark Pharmaceuticals, Inc., USA., and Lannett Company, Inc. Elite currently has eleven approved generic products, two which are pending launch, another two generic products are filed with the FDA, and an NDA filed for SequestOx(TM). Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. Learn more at www.elitepharma.com.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.